| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003.
|
J Clin Oncol
|
2007
|
3.32
|
|
2
|
Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004.
|
Br J Haematol
|
2008
|
3.21
|
|
3
|
Solid cancers after allogeneic hematopoietic cell transplantation.
|
Blood
|
2008
|
2.56
|
|
4
|
Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS).
|
Blood
|
2011
|
2.54
|
|
5
|
Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus.
|
JAMA
|
2007
|
2.51
|
|
6
|
Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008.
|
J Clin Oncol
|
2011
|
2.34
|
|
7
|
Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003.
|
Int J Cancer
|
2007
|
2.16
|
|
8
|
Racial disparities in incidence and outcome in multiple myeloma: a population-based study.
|
Blood
|
2010
|
2.12
|
|
9
|
Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes.
|
J Clin Oncol
|
2011
|
2.11
|
|
10
|
Control of autophagic cell death by caspase-10 in multiple myeloma.
|
Cancer Cell
|
2013
|
2.06
|
|
11
|
Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesis.
|
Br J Haematol
|
2007
|
2.02
|
|
12
|
Free light chains and the risk of AIDS-defining opportunistic infections in HIV-infected individuals.
|
Clin Infect Dis
|
2012
|
2.01
|
|
13
|
Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies.
|
Int J Cancer
|
2009
|
2.01
|
|
14
|
Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study.
|
Blood
|
2010
|
1.89
|
|
15
|
Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based study.
|
J Clin Oncol
|
2009
|
1.88
|
|
16
|
Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders.
|
Blood
|
2008
|
1.80
|
|
17
|
Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.
|
Hepatology
|
2009
|
1.80
|
|
18
|
Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma.
|
Blood
|
2008
|
1.78
|
|
19
|
Minimal residual disease: what are the minimum requirements?
|
J Clin Oncol
|
2014
|
1.76
|
|
20
|
Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden.
|
Blood
|
2013
|
1.64
|
|
21
|
Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden.
|
Blood
|
2008
|
1.62
|
|
22
|
Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005.
|
Blood
|
2008
|
1.61
|
|
23
|
Hematopoietic malignancies associated with viral and alcoholic hepatitis.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.59
|
|
24
|
Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology.
|
Br J Haematol
|
2007
|
1.54
|
|
25
|
International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation.
|
J Clin Oncol
|
2014
|
1.52
|
|
26
|
Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms.
|
J Clin Oncol
|
2011
|
1.51
|
|
27
|
Concomitant and antecedent deep venous thrombosis and cancer survival in male US veterans.
|
Leuk Lymphoma
|
2011
|
1.50
|
|
28
|
Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia.
|
Haematologica
|
2009
|
1.50
|
|
29
|
Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma.
|
Arthritis Rheum
|
2008
|
1.50
|
|
30
|
Immunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy era.
|
J Acquir Immune Defic Syndr
|
2010
|
1.47
|
|
31
|
Second malignancies after multiple myeloma: from 1960s to 2010s.
|
Blood
|
2012
|
1.46
|
|
32
|
Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study.
|
J Clin Oncol
|
2012
|
1.46
|
|
33
|
Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.45
|
|
34
|
Borrelia and subsequent risk of solid tumors and hematologic malignancies in Sweden.
|
Int J Cancer
|
2012
|
1.39
|
|
35
|
Cancer risk among patients with myotonic muscular dystrophy.
|
JAMA
|
2011
|
1.38
|
|
36
|
Serum free light chains as predictors of lymphomagenesis in patients with autosomal dominant hyper-immunoglobulin E syndrome (Job's syndrome).
|
Leuk Lymphoma
|
2012
|
1.38
|
|
37
|
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies.
|
Blood
|
2011
|
1.37
|
|
38
|
Increased risk for non-Hodgkin lymphoma in individuals with celiac disease and a potential familial association.
|
Gastroenterology
|
2008
|
1.36
|
|
39
|
Autoimmunity and lymphomagenesis.
|
Int J Cancer
|
2009
|
1.29
|
|
40
|
IMWG consensus on maintenance therapy in multiple myeloma.
|
Blood
|
2012
|
1.29
|
|
41
|
Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans.
|
Cancer
|
2010
|
1.25
|
|
42
|
Autoimmunity and the risk of myeloproliferative neoplasms.
|
Haematologica
|
2010
|
1.25
|
|
43
|
Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia.
|
J Natl Cancer Inst
|
2010
|
1.24
|
|
44
|
Improved survival in chronic lymphocytic leukemia in the past decade: a population-based study including 11,179 patients diagnosed between 1973-2003 in Sweden.
|
Haematologica
|
2009
|
1.21
|
|
45
|
Myeloma and second primary cancers.
|
N Engl J Med
|
2011
|
1.20
|
|
46
|
Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study.
|
Haematologica
|
2009
|
1.19
|
|
47
|
Highly increased familial risks for specific lymphoma subtypes.
|
Br J Haematol
|
2009
|
1.16
|
|
48
|
Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study.
|
Blood
|
2009
|
1.15
|
|
49
|
Chronic immune stimulation and subsequent Waldenström macroglobulinemia.
|
Arch Intern Med
|
2008
|
1.14
|
|
50
|
Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27 years follow-up.
|
Haematologica
|
2013
|
1.14
|
|
51
|
Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden.
|
Int J Cancer
|
2009
|
1.12
|
|
52
|
Racial differences in chronic immune stimulatory conditions and risk of non-Hodgkin's lymphoma in veterans from the United States.
|
J Clin Oncol
|
2010
|
1.11
|
|
53
|
Cancer incidence among pesticide applicators exposed to permethrin in the Agricultural Health Study.
|
Environ Health Perspect
|
2008
|
1.09
|
|
54
|
Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study.
|
Blood
|
2010
|
1.09
|
|
55
|
Polyclonal immunoglobulin free light chains as a potential biomarker of immune stimulation and inflammation.
|
Clin Chem
|
2011
|
1.06
|
|
56
|
Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infection.
|
Arch Intern Med
|
2009
|
1.06
|
|
57
|
Modeling progression risk for smoldering multiple myeloma: results from a prospective clinical study.
|
Leuk Lymphoma
|
2013
|
1.06
|
|
58
|
MYD88 L265P somatic mutation in IgM MGUS.
|
N Engl J Med
|
2012
|
1.06
|
|
59
|
Minimal residual disease testing in multiple myeloma by flow cytometry: major heterogeneity.
|
Blood
|
2013
|
1.06
|
|
60
|
Patterns of survival in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: a population-based study of 1,555 patients diagnosed in Sweden from 1980 to 2005.
|
Am J Hematol
|
2012
|
1.05
|
|
61
|
Common community acquired infections and subsequent risk of chronic lymphocytic leukaemia.
|
Br J Haematol
|
2009
|
1.04
|
|
62
|
Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies.
|
Haematologica
|
2009
|
1.03
|
|
63
|
Increased risk for lymphoid and myeloid neoplasms in elderly solid-organ transplant recipients.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.03
|
|
64
|
Bortezomib to treat the TEMPI syndrome.
|
N Engl J Med
|
2012
|
1.02
|
|
65
|
Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium.
|
Blood
|
2012
|
1.01
|
|
66
|
Risks of cancer among a cohort of 23,935 men and women with osteoporosis.
|
Int J Cancer
|
2008
|
1.00
|
|
67
|
Familial aggregation of acute myeloid leukemia and myelodysplastic syndromes.
|
J Clin Oncol
|
2011
|
1.00
|
|
68
|
High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma.
|
Blood
|
2004
|
1.00
|
|
69
|
Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma.
|
Blood
|
2003
|
1.00
|
|
70
|
The kinetics and reproducibility of 18F-sodium fluoride for oncology using current PET camera technology.
|
J Nucl Med
|
2012
|
0.98
|
|
71
|
Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL).
|
Cytometry B Clin Cytom
|
2010
|
0.98
|
|
72
|
A prospective study of circulating adipokine levels and risk of multiple myeloma.
|
Blood
|
2012
|
0.97
|
|
73
|
Current and future imaging modalities for multiple myeloma and its precursor states.
|
Leuk Lymphoma
|
2011
|
0.97
|
|
74
|
Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic.
|
Mayo Clin Proc
|
2010
|
0.96
|
|
75
|
Common genetic variants in candidate genes and risk of familial lymphoid malignancies.
|
Br J Haematol
|
2009
|
0.96
|
|
76
|
Chronic lymphocytic leukaemia genetics overview.
|
Br J Haematol
|
2007
|
0.95
|
|
77
|
Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study.
|
Haematologica
|
2011
|
0.94
|
|
78
|
Accuracy of ICD-9-CM codes in identifying infections of pneumonia and herpes simplex virus in administrative data.
|
Ann Epidemiol
|
2013
|
0.94
|
|
79
|
A population-based assessment of mortality and morbidity patterns among patients with thymoma.
|
Int J Cancer
|
2010
|
0.93
|
|
80
|
No familial aggregation in chronic myeloid leukemia.
|
Blood
|
2013
|
0.92
|
|
81
|
Progress in Hodgkin lymphoma: a population-based study on patients diagnosed in Sweden from 1973-2009.
|
Blood
|
2011
|
0.92
|
|
82
|
Prevalence of monoclonal B-cell lymphocytosis: a systematic review.
|
Cytometry B Clin Cytom
|
2010
|
0.92
|
|
83
|
Plasma cell neoplasms in US solid organ transplant recipients.
|
Am J Transplant
|
2013
|
0.92
|
|
84
|
Circulating cytokine levels, Epstein-Barr viremia, and risk of acquired immunodeficiency syndrome-related non-Hodgkin lymphoma.
|
Am J Hematol
|
2011
|
0.91
|
|
85
|
Novel aspects pertaining to the relationship of Waldenström's macroglobulinemia, IgM monoclonal gammopathy of undetermined significance, polyclonal gammopathy, and hypoglobulinemia.
|
Clin Lymphoma Myeloma
|
2009
|
0.91
|
|
86
|
Challenges and opportunities of novel imaging techniques in monoclonal plasma cell disorders: imaging "early myeloma".
|
Leuk Lymphoma
|
2013
|
0.90
|
|
87
|
Increased levels of circulating cytokines with HIV-related immunosuppression.
|
AIDS Res Hum Retroviruses
|
2011
|
0.90
|
|
88
|
Multidrug resistance in relapsed acute myeloid leukemia: evidence of biological heterogeneity.
|
Cancer
|
2013
|
0.90
|
|
89
|
Hepatitis C virus infection and risk of posttransplantation lymphoproliferative disorder among solid organ transplant recipients.
|
Blood
|
2007
|
0.90
|
|
90
|
A method to visualize and adjust for selection bias in prevalent cohort studies.
|
Am J Epidemiol
|
2011
|
0.90
|
|
91
|
Timing of births and endometrial cancer risk in Swedish women.
|
Cancer Causes Control
|
2009
|
0.89
|
|
92
|
Familial Aspects of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and Related Lymphomas.
|
European J Clin Med Oncol
|
2010
|
0.88
|
|
93
|
Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndrome.
|
BMC Med Genet
|
2010
|
0.88
|
|
94
|
Hodgkin lymphoma among US solid organ transplant recipients.
|
Transplantation
|
2010
|
0.88
|
|
95
|
Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis.
|
Expert Rev Mol Diagn
|
2010
|
0.87
|
|
96
|
Autoimmunity and hematologic malignancies: associations and mechanisms.
|
Leuk Lymphoma
|
2009
|
0.86
|
|
97
|
Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study.
|
Blood
|
2011
|
0.86
|
|
98
|
Plasma markers of B-cell activation and clonality in pediatric liver and hematopoietic stem cell transplant recipients.
|
Transplantation
|
2013
|
0.86
|
|
99
|
Survival patterns among lymphoma patients with a family history of lymphoma.
|
J Clin Oncol
|
2008
|
0.86
|
|
100
|
Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases.
|
Vaccine
|
2005
|
0.86
|
|
101
|
Thrombosis is associated with inferior survival in multiple myeloma.
|
Haematologica
|
2012
|
0.86
|
|
102
|
Smoldering (asymptomatic) multiple myeloma: revisiting the clinical dilemma and looking into the future.
|
Clin Lymphoma Myeloma Leuk
|
2010
|
0.85
|
|
103
|
Bone disease from monoclonal gammopathy of undetermined significance to multiple myeloma: pathogenesis, interventions, and future opportunities.
|
Semin Hematol
|
2011
|
0.85
|
|
104
|
Prior autoimmune disease and risk of monoclonal gammopathy of undetermined significance and multiple myeloma: a systematic review.
|
Cancer Epidemiol Biomarkers Prev
|
2014
|
0.84
|
|
105
|
Increased incidence of chronic lymphocytic leukaemia and lymphomas in patients with Merkel cell carcinoma - a population based study of 335 cases with neuroendocrine skin tumour.
|
Br J Haematol
|
2012
|
0.84
|
|
106
|
Bone disease in multiple myeloma and precursor disease: novel diagnostic approaches and implications on clinical management.
|
Expert Rev Mol Diagn
|
2011
|
0.84
|
|
107
|
MGUS prevalence in an ethnically Chinese population in Hong Kong.
|
Blood
|
2013
|
0.84
|
|
108
|
Risk of solid tumors and myeloid hematological malignancies among first-degree relatives of patients with monoclonal gammopathy of undetermined significance.
|
Haematologica
|
2009
|
0.83
|
|
109
|
Molecular imaging in myeloma precursor disease.
|
Semin Hematol
|
2011
|
0.83
|
|
110
|
Patterns of monoclonal immunoglobulins and serum free light chains are significantly different in black compared to white monoclonal gammopathy of undetermined significance (MGUS) patients.
|
Am J Hematol
|
2011
|
0.83
|
|
111
|
Prior history of non-melanoma skin cancer is associated with increased mortality in patients with chronic lymphocytic leukemia.
|
Haematologica
|
2009
|
0.82
|
|
112
|
Mantle cell lymphomas with clonal immunoglobulin V(H)3-21 gene rearrangements exhibit fewer genomic imbalances than mantle cell lymphomas utilizing other immunoglobulin V(H) genes.
|
Mod Pathol
|
2005
|
0.82
|
|
113
|
Current insight on trends, causes, and mechanisms of Hodgkin's lymphoma.
|
Cancer J
|
2009
|
0.82
|
|
114
|
Autoimmunity and risk for Hodgkin's lymphoma by subtype.
|
Haematologica
|
2009
|
0.82
|
|
115
|
Re: Familial clustering of Hodgkin lymphoma and multiple sclerosis.
|
J Natl Cancer Inst
|
2005
|
0.82
|
|
116
|
Response to splenectomy is durable after a certain point in time in adult patients with chronic immune thrombocytopenic purpura.
|
Eur J Haematol
|
2006
|
0.81
|
|
117
|
The proteasome: mechanisms of biology and markers of activity and response to treatment in multiple myeloma.
|
Leuk Lymphoma
|
2014
|
0.81
|
|
118
|
Pursuing the curative blueprint for early myeloma.
|
Blood
|
2013
|
0.81
|
|
119
|
Genetics- and immune-related factors in the pathogenesis of lymphoplasmacytic lymphoma/ Waldenström's macroglobulinemia.
|
Clin Lymphoma Myeloma
|
2009
|
0.81
|
|
120
|
Immune thrombocytopenic purpura does not exhibit a disparity in prevalence between African American and White veterans.
|
Blood
|
2006
|
0.81
|
|
121
|
BCL-6 and rituximab in diffuse large B-cell lymphoma: where are we?
|
Blood
|
2007
|
0.81
|
|
122
|
Hypercoagulability in multiple myeloma and its precursor state, monoclonal gammopathy of undetermined significance.
|
Semin Hematol
|
2011
|
0.80
|
|
123
|
Role of microRNAs from monoclonal gammopathy of undetermined significance to multiple myeloma.
|
Semin Hematol
|
2011
|
0.80
|
|
124
|
Etiology of Waldenström macroglobulinemia: genetic factors and immune-related conditions.
|
Clin Lymphoma Myeloma Leuk
|
2013
|
0.80
|
|
125
|
Molecular and biologic markers of progression in monoclonal gammopathy of undetermined significance to multiple myeloma.
|
Leuk Lymphoma
|
2010
|
0.79
|
|
126
|
Evolution of a precursor.
|
Cytometry B Clin Cytom
|
2010
|
0.79
|
|
127
|
Survival in monoclonal gammopathy of undetermined significance and Waldenström macroglobulinemia.
|
Clin Lymphoma Myeloma Leuk
|
2013
|
0.79
|
|
128
|
Multiple myeloma precursor disease: current clinical dilemma and future opportunities.
|
Semin Hematol
|
2011
|
0.79
|
|
129
|
Temporal trends in the proportion cured among adults diagnosed with acute myeloid leukaemia in Sweden 1973-2001, a population-based study.
|
Br J Haematol
|
2009
|
0.79
|
|
130
|
Hodgkin lymphoma risk following infectious and chronic inflammatory diseases: a large population-based case-control study from Sweden.
|
Int J Hematol
|
2015
|
0.78
|
|
131
|
Monoclonal B cell lymphocytosis: clinical and population perspectives.
|
Cytometry B Clin Cytom
|
2010
|
0.78
|
|
132
|
Germline and somatic JAK2 mutations and susceptibility to chronic myeloproliferative neoplasms.
|
Genome Med
|
2009
|
0.78
|
|
133
|
Evolving therapeutic paradigms for multiple myeloma: back to the future.
|
Leuk Lymphoma
|
2012
|
0.78
|
|
134
|
Associations between non-Hodgkin lymphoma and renal cell carcinoma.
|
Leuk Lymphoma
|
2011
|
0.78
|
|
135
|
The effects of cardiovascular disease on the clinical outcome of elderly patients with diffuse large B-cell lymphoma.
|
Leuk Lymphoma
|
2014
|
0.78
|
|
136
|
Familial longevity: the older you are, the older your father may have been.
|
J Am Geriatr Soc
|
2005
|
0.77
|
|
137
|
Novel therapies in multiple myeloma for newly diagnosed nontransplant candidates.
|
Cancer J
|
2009
|
0.77
|
|
138
|
MGUS prevalence in a cohort of AML patients.
|
Blood
|
2013
|
0.77
|
|
139
|
Quantifying cancer absolute risk and cancer mortality in the presence of competing events after a myotonic dystrophy diagnosis.
|
PLoS One
|
2013
|
0.77
|
|
140
|
Infection in infancy and subsequent risk of developing lymphoma in children and young adults.
|
Blood
|
2010
|
0.77
|
|
141
|
Smoldering multiple myeloma: present position and potential promises.
|
Eur J Haematol
|
2013
|
0.77
|
|
142
|
Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.
|
Int J Cancer
|
2014
|
0.77
|
|
143
|
Intravoxel incoherent motion imaging for assessment of bone marrow infiltration of monoclonal plasma cell diseases.
|
Ann Hematol
|
2013
|
0.76
|
|
144
|
Lack of MYD88 L265P in non-immunoglobulin M lymphoplasmacytic lymphoma.
|
Leuk Lymphoma
|
2013
|
0.76
|
|
145
|
Antigenic drift in relapsed extramedullary multiple myeloma: plasma cells without CD38 expression.
|
Leuk Lymphoma
|
2011
|
0.76
|
|
146
|
What causes Waldenström's macroglobulinemia: genetic or immune-related factors, or a combination?
|
Clin Lymphoma Myeloma Leuk
|
2011
|
0.76
|
|
147
|
Prevalence, clinical aspects, and natural history of IgM MGUS.
|
Cytometry B Clin Cytom
|
2010
|
0.76
|
|
148
|
Shared susceptibility for celiac disease and inflammatory bowel disease?
|
Scand J Gastroenterol
|
2008
|
0.75
|
|
149
|
HIV, EBV, and monoclonal gammopathy.
|
Blood
|
2013
|
0.75
|
|
150
|
High prevalence of polyclonal hypergamma-globulinemia in adult males in Ghana, Africa.
|
Am J Hematol
|
2011
|
0.75
|
|
151
|
Reply to bibas et Al.
|
Clin Infect Dis
|
2013
|
0.75
|
|
152
|
Familial aggregation of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia with solid tumors and myeloid malignancies.
|
Acta Haematol
|
2012
|
0.75
|
|
153
|
Common community-acquired infections and subsequent risk of multiple myeloma: a population-based study.
|
Int J Cancer
|
2013
|
0.75
|
|
154
|
Re: Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials.
|
J Natl Cancer Inst
|
2009
|
0.75
|
|
155
|
A case study progression to multiple myeloma.
|
Clin J Oncol Nurs
|
2010
|
0.75
|
|
156
|
Parental longevity and prognosis in elderly patients with aggressive non-Hodgkin's lymphoma.
|
Acta Oncol
|
2004
|
0.75
|
|
157
|
Molecular cytogenetic approach to the diagnosis of splenic lymphoma: a case report of blastoid mantle cell lymphoma.
|
Leuk Lymphoma
|
2003
|
0.75
|
|
158
|
Autologous haematopoietic stem cell transplantation in multiple myeloma patients from ethnic minority groups in an equal access healthcare system.
|
Br J Haematol
|
2011
|
0.75
|
|
159
|
Immunoparesis and monoclonal gammopathy of undetermined significance are disassociated in advanced age.
|
Am J Hematol
|
2012
|
0.75
|
|
160
|
Flow cytometric sensitivity and characteristics of plasma cells in patients with multiple myeloma or its precursor disease: influence of biopsy site and anticoagulation method.
|
Leuk Lymphoma
|
2014
|
0.75
|
|
161
|
Thromboprophylaxis in multiple myeloma: is the evidence there?
|
Expert Rev Anticancer Ther
|
2012
|
0.75
|